About Amuna Pharmaceuticals
Amuna Pharmaceuticals is a company based in Cranbury (United States) founded in 2018 by Chaudhary Manohar Lal and Nirav Nalinkumar Vyas. The company has 4 employees as of April 10, 2024. Amuna Pharmaceuticals offers products and services including Synthetic Chemistry Services, Medicinal Chemistry Services, and API Manufacturing. Amuna Pharmaceuticals operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Cranbury, United States
- Employees 4 as on 10 Apr, 2024
- Founders Chaudhary Manohar Lal, Nirav Nalinkumar Vyas
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Amuna Pharmaceuticals Llp
- Date of Incorporation 09 Aug, 2018
- Jurisdiction Ahmadabad City, Gujarat, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
4
as on Apr 10, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amuna Pharmaceuticals
Amuna Pharmaceuticals offers a comprehensive portfolio of products and services, including Synthetic Chemistry Services, Medicinal Chemistry Services, and API Manufacturing.
Provides custom synthesis for drug discovery projects.
Supports hit-to-lead and lead optimization in pharmaceuticals.
Handles end-to-end active pharmaceutical ingredient development.
Funding Insights of Amuna Pharmaceuticals
Detailed funding history for Amuna Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amuna Pharmaceuticals
Investment portfolio details for Amuna Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Amuna Pharmaceuticals
Detailed financials for Amuna Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amuna Pharmaceuticals Comparisons
Peer comparison for Amuna Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Amuna Pharmaceuticals
Amuna Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Amuna Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amuna Pharmaceuticals
Complete news archive for Amuna Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amuna Pharmaceuticals
Amuna Pharmaceuticals was founded in 2018.
Amuna Pharmaceuticals is headquartered in Cranbury, United States. It is registered at Cranbury, New Jersey, United States.
Nirav Nalinkumar Vyas is the current CEO of Amuna Pharmaceuticals. They have also founded this company.
As of Apr 10, 2024, the latest employee count at Amuna Pharmaceuticals is 4.
Amuna Pharmaceuticals was established in 2018 and is based in Cranbury, United States. Operations focus on the pharmaceutical sector, where research and development of active pharmaceutical ingredients (APIs) are carried out alongside their manufacturing. The company serves as a provider in this domain, with leadership including co-founders Chaudhary Manohar Lal and Nirav Nalinkumar Vyas, who holds the CEO position. Activities are centered on API production for broader industry applications.
Amuna Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Amuna Pharmaceuticals offers Synthetic Chemistry Services, Medicinal Chemistry Services, and API Manufacturing.